These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18326326)

  • 41. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. BCSH Blood Transfusion Task Force.
    Transfus Med; 1996 Sep; 6(3):273-83. PubMed ID: 8885158
    [No Abstract]   [Full Text] [Related]  

  • 42. Hemolytic transfusion reaction due to interdonor kell incompatibility. Report of two cases and review of the literature.
    Reiner AP; Sayers MH
    Arch Pathol Lab Med; 1990 Aug; 114(8):862-4. PubMed ID: 2198004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Strategies for prevention of adverse transfusion effects. Immediate and delayed transfusion effects: laboratory reference for transfusion reactions].
    Kiyokawa H
    Rinsho Byori; 1991 Mar; Suppl 88():128-37. PubMed ID: 1856964
    [No Abstract]   [Full Text] [Related]  

  • 44. [Necessity of a 24-hour system of blood transfusion testing].
    Kishimoto Y
    Rinsho Byori; 2003 Jan; 51(1):50-6. PubMed ID: 12652691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The basics of transfusion. 1. General transfusion methods and treatment with erythrocyte concentrates].
    Michaelis C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Mar; 33(3):177-98. PubMed ID: 9581232
    [No Abstract]   [Full Text] [Related]  

  • 46. What every physician should know about transfusion reactions.
    Bakdash S; Yazer MH
    CMAJ; 2007 Jul; 177(2):141-7. PubMed ID: 17638948
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunohematology and transfusion reaction.
    Jocius M
    AANA J; 1982 Feb; 50(1):42-8. PubMed ID: 7072458
    [No Abstract]   [Full Text] [Related]  

  • 48. [Blood transfusion complications due to factor hr'(c) incompatibility in patients with rhesus-positive blood].
    Skachilova NN; Umnova MA; Ichalovskaia TA; Beliaev VV; Oshkina NP
    Probl Gematol Pereliv Krovi; 1980 Feb; 25(2):35-41. PubMed ID: 6767234
    [No Abstract]   [Full Text] [Related]  

  • 49. Blood transfusion.
    Atterbury C; Wilkinson J
    Nurs Stand; 2000 May 10-16; 14(34):47-52; quiz 53-4. PubMed ID: 11974045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Characteristics of anti-Coa antibodies of the Colton blood group system and their significance in hemotherapy].
    KuĊ›nierz G; Bragiel I; Nowakowska E; Cwirko Z
    Acta Haematol Pol; 1983; 14(2):117-24. PubMed ID: 6673468
    [No Abstract]   [Full Text] [Related]  

  • 51. [Immunological blood transfusion safety and selection of red blood cells issued from hospital blood banks].
    Py JY
    Transfus Clin Biol; 2010 Dec; 17(5-6):334-40. PubMed ID: 21050787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elimination of blood group antigens: hope and reality.
    Bagnis C; Chiaroni J; Bailly P
    Br J Haematol; 2011 Feb; 152(4):392-400. PubMed ID: 21210778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mismatched blood transfusion. A case report.
    Moyes DG; Miller MT; Blumberg L
    S Afr Med J; 1985 Aug; 68(4):260. PubMed ID: 4035484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The management of immediate transfusion reactions.
    Mahasandana S
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):199-203. PubMed ID: 524142
    [No Abstract]   [Full Text] [Related]  

  • 55. [Indications for the use of blood products and blood substitutes].
    Reissigl H
    Beitr Infusionther Klin Ernahr; 1979; 2():99-117. PubMed ID: 575484
    [No Abstract]   [Full Text] [Related]  

  • 56. Transfusion therapy.
    Gianino N; Rutman R; Casey D; Anderson-Protzel C; Miller WV
    Crit Care Update; 1980 May; 7(5):5-26. PubMed ID: 6899989
    [No Abstract]   [Full Text] [Related]  

  • 57. [Computer management to avoid errors in transfusion].
    Takahashi K
    Rinsho Byori; 2003 Jan; 51(1):63-70. PubMed ID: 12652693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [2nd revision consensus on blood transfusion. Central Guidance Organization for Peer Review].
    van Aken WG; Dinkelaar RB; Gorgels JP; Knape JT; van Everdingen JJ
    Ned Tijdschr Geneeskd; 1998 Feb; 142(6):298-300. PubMed ID: 9562730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cross matching test].
    Kitamura K
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():709-12. PubMed ID: 16111376
    [No Abstract]   [Full Text] [Related]  

  • 60. Consecutive national surveys of ABO-incompatible blood transfusion in Japan.
    Fujii Y; Shibata Y; Miyata S; Inaba S; Asai T; Hoshi Y; Takamatsu J; Takahashi K; Ohto H; Juji T; Sagawa K
    Vox Sang; 2009 Oct; 97(3):240-6. PubMed ID: 19476605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.